Install
Inside Precision Medicine is the only global media brand covering the full spectrum of precision medicine, taking a wide lens approach while bringing into sharp focus the many complex and interconnected issues that constitute the field.
- 48articles · 30d
- 2+ day agolatest article
- Aug 17, 2026earliest in window
- 98%with images
- 339avg words
- Health & Wellness 46
- Medical 45
- Health 40
- Science & Technology 8
- Science & Nature 3
- People & Society 1
- STEM 1
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Prostate Cancer Genomic Analysis Links Mutational Footprints to Clinical Outcomes
4+ day, 14+ hour ago (318+ words) An analysis of nearly 1000 prostate tumor samples has revealed eight integrated mutational footprints (IMFs) that underpin the majority of genetic alterations found in prostate cancer genomes, some of which reflect clinical outcomes. Although prostate cancer has a high prevalence, the…...
Targetable KRAS G12C Mutation Uncommon in Genitourinary Cancers
4+ day, 18+ hour ago (474+ words) A comprehensive genomic profiling study involving more than 13,000 patients has shown that targetable G12C mutations in the KRAS oncogene are rare in genitourinary cancers, potentially limiting the role of routine testing and targeted treatment in these malignancies. KRAS G12C accounts for approximately…...
Tumors Use Antioxidant Protein to Disarm Cancer-Fighting T Cells
1+ week, 2+ day ago (450+ words) Reactive oxygen species are usually cast as the villains in cancer, capable of damaging DNA and promoting tumor growth. But new research shows that cancer-fighting T cells need small amounts of these molecules—and tumors may exploit that dependence to…...
How Cancer-Causing Proteins Accumulate May Shape Response to PROTACs
1+ week, 4+ day ago (763+ words) The genetic mechanism driving an oncogene could help determine whether a tumor responds to protein-degrading therapies, potentially providing a new consideration for selecting patients for this emerging class of cancer drugs. The results suggest that tumors in which an oncogene…...
'TumorDressed' Allogeneic Dendritic Cells Trigger Personalized Anti-Tumor Cytotoxicity
2+ week, 4+ day ago (742+ words) A new cancer immunotherapy strategy aims to turn an abundant laboratory-grown cell source into a personalized teacher for the immune system—showing a patient’s T cells not just one tumor target, but potentially the full array of targets displayed by…...
Molecular Switch Driving Triple-Negative Breast Cancer Metastasis Identified
3+ week, 2+ day ago (327+ words) The study focuses less on the primary tumor and more on what makes disseminated cancer cells grow into clinically dangerous metastases. Many TNBC patients can have their primary tumor treated successfully, but outcomes worsen sharply once the disease spreads to…...
Prostate Cancer Rewires Amino Acid Metabolism to Drive Treatment Resistance
3+ week, 3+ day ago (397+ words) Researchers at Weill Cornell Medicine have identified a previously unknown link between amino acid metabolism and prostate cancer’s resistance to hormone therapy. Published in Nature Metabolism, the preclinical study found that prostate cancer cells can hijack the metabolism of two…...